Asthma Clinical Trial
Official title:
Effects of Educational Intervention on Long-Term Outcomes of Hospitalized Children With Asthma
The investigators hypothesize that reinforced asthma education improves long-term outcomes in
children with asthma.
Specific Aims and Objectives:
1. To determine the retention rate of parental knowledge about asthma;
2. To evaluate the clinical status, quality of life and healthcare costs of children with
asthma following an educational intervention.
This study will be a prospective, randomized (1:1), controlled study assessing clinical
status, quality of life, healthcare costs and parental retention rate of asthma knowledge for
children 5 to 12 years old with asthma, following standardized asthma education versus
standard education with an enhanced reinforcement of education intervention.
Group A (the intervention group) The caregivers of the subjects enrolled in this group will
be administered two survey instruments at enrollment (t0), and again via telephone at 2 weeks
(t1), 1 months (t2), and 3 months (t3) after enrollment. This group will also receive
reinforced asthma education via telephone at 2 weeks, 1 month, and 3 months after enrollment.
Group B (the control group) The caregivers of the subjects enrolled in this group will be
administered two survey instruments at enrollment (t0), and again via telephone at 2 weeks
(t1), 1 month (t2), and 3 months (t3) after enrollment. This group will not receive
reinforcing of the asthma education at 2 weeks, 1 month, and 3 months after enrollment.
The two survey instruments administered to the caregivers (parents/legal guardians) of the
subjects enrolled in this study consist of:
1. A validated 16-item questionnaire with multiple-choice answers, assessing asthma
knowledge, trigger identification and avoidance, referred to as "the Asthma Knowledge
Quiz" from here on.
2. A validated 5-item questionnaire with multiple-choice answers, assessing the patient's
quality of life and asthma control, referred to as "the Quality of Life/Asthma Control
Test (QOL/ACT) survey" from here on.
Following enrollment and randomization, the caregiver of each subject will be administered
the two survey instruments prior to discharge from the hospital.
At the end of the administration of the phone surveys (i.e. at 2 weeks, 1 month and 3 months
following enrollment), the study coordinator will provide reinforced asthma education to the
caregiver via telephone for the subjects enrolled in Group A (the intervention group). The
reinforced asthma education will be consistent with the asthma education training session
delivered by the AE before the beginning of the study.
The survey instruments will be administered to the caregiver by the study coordinator in
paper form; after completion by the caregiver, the form will be saved in the subject's
research binder for further data analysis. The PI or the study coordinator will determine the
score for each item on the surveys, and record the scores in the subject's file, in the
Asthma Knowledge Quiz Scores/Asthma Knowledge Retention Rates Form, and the Quality of
Life/Asthma Control Test (QOL/ACT) Scores Form respectively.
The caregiver of each subject will be administered these two survey instruments again, via
telephone, by the study coordinator, at 2 weeks, 1 month, and 3 months after enrollment. Each
item and the multiple-choice answers will be literally read to the parent over the phone, and
the study coordinator will record the answers to each item on the paper survey forms, which
will be saved in the subject's binder for further data analysis. The PI or the study
coordinator will determine the score for each survey, and record the scores in the subject's
file.
A variety of statistical techniques will be used to analyze the data. The investigators will
perform descriptive analyses as well as more analytic work using analysis of variance,
correlation and multiple regression analysis. The investigators will use the expertise of a
biostatistician to assist with accurate analysis of our data. The study will be powered to
detect a significant difference in outcomes between the intervention group (group A) and the
control group (group B); 25 % reduction in cost an 25% improvement in quality of life scores,
following reinforced asthma education, with a 95% CI (alpha=0.05, beta=0.2, for a power of
80%). The investigators will also analyze whether there is a statistically significant
correlation between the amplitude of the asthma knowledge scores (AKS) and the asthma
knowledge retention rates (AKRR) on one side and the QOL/ACT scores, functional status and
asthma related healthcare costs on the other side.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04624425 -
Additional Effects of Segmental Breathing In Asthma
|
N/A | |
| Terminated |
NCT04410523 -
Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
|
Phase 2 | |
| Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
| Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
| Recruiting |
NCT03694158 -
Investigating Dupilumab's Effect in Asthma by Genotype
|
Phase 4 | |
| Terminated |
NCT04946318 -
Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04450108 -
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
|
N/A | |
| Completed |
NCT03086460 -
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
|
Phase 2 | |
| Completed |
NCT01160224 -
Oral GW766944 (Oral CCR3 Antagonist)
|
Phase 2 | |
| Completed |
NCT03186209 -
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
|
Phase 3 | |
| Completed |
NCT02502734 -
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
|
Phase 3 | |
| Completed |
NCT01715844 -
L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics
|
Phase 1 | |
| Terminated |
NCT04993443 -
First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036
|
Phase 1 | |
| Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
| Recruiting |
NCT06033833 -
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
|
Phase 2 | |
| Completed |
NCT03257995 -
Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
|
Phase 2 | |
| Completed |
NCT02212483 -
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients
|
N/A | |
| Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
| Withdrawn |
NCT01468805 -
Childhood Asthma Reduction Study
|
N/A | |
| Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|